Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 212 M230 M268 M308 M173 M 979 M Research & development 856 M700 M801 M775 M649 M 2.92 B Operating income -1.05 B-907 M-260 M-857 M-1.39 B -3.41 B Non-Operating Income, Total 97 M107 M93 M68 M63 M 331 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 101 M99 M93 M80 M81 M 353 M Unusual income/expense -4 M8 M0-12 M-18 M -22 M Pretax income -964 M-818 M-187 M-799 M-1.33 B -3.14 B Equity in earnings -8 M03 M-3 M-2 M -2 M Taxes 7 M7 M13 M27 M9 M 56 M Non-controlling/minority interest ————— — After tax other income/expense -2 M-34 M-14 M-27 M-6 M -81 M Net income before discontinued operations -971 M-825 M-200 M-826 M-1.34 B -3.19 B Discontinued operations ————— — Net income -971 M-825 M-200 M-826 M-1.34 B -3.19 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -971 M-825 M-200 M-826 M-1.34 B -3.19 B Basic earnings per share (Basic EPS) -2.52-2.13-0.51-2.1-3.4 -8.14 Diluted earnings per share (Diluted EPS) -2.52-2.13-0.51-2.1-3.4 -8.14 Average basic shares outstanding 386 M388 M390 M389 M395 M — Diluted shares outstanding 386 M388 M390 M389 M395 M — EBITDA -1.01 B-851 M-209 M-791 M-1.33 B -3.18 B EBIT -1.05 B-907 M-260 M-857 M-1.39 B -3.41 B Cost of revenue 90 M119 M207 M452 M955 M 1.73 B Other cost of goods sold 52 M45 M74 M144 M38 M 301 M Depreciation & amortization (cash flow) 38 M56 M51 M66 M56 M 229 M
News
S&P 500 Top Stock Gainers Today, 7/10/26 - TipRanks.com
MRK Surpasses 50- & 200-Day SMAs: Buy, Hold or Sell at Current Levels?
ValuEngine Weekly Market Summary And Commentary
Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know
US payroll miss sends Fed hike bets lower | Week of 6 Jul
2 More Stocks to Buy for the AI Convergence
Stock Market Week Ahead: Oil Hints At A Paradigm Shift
MRNA Stock on the Move: What Sparked the 33.5% Jump in the Past Week?
S&P 500 Top Stock Gainers Today, 7/2/26 - TipRanks.com
Sandisk Leads Seven S&P 500 Stocks That Have Skyrocketed In 2026
Vertex Pharmaceuticals Has One Of The Widest And Most Durable Moats In Biotech (VRTX)
Charts & Ideas
MRNA - Long-Term Technical Forecast
Weekly price is located above Ichimoku cloud in the bullish area of the chart for trying to cross the level at 81.36 to above for the strong bullish trend to be continuing. The price is on strong bullish breakout which is confirmed by Stochastic oscillator and Chinkou Span line. If the price breaks the 81.36 level to above on weekly close bar so the strong bullish trend will be continuing. If the price crosses the level at 73.28 to below so the secondary correction will be started. If the price breaks the support level at 43.90 to 36.66 to be crossed on weekly close bar so we may see the primary bearish reversal to be started on this W1 timeframe for example. Alternatively, the price will be on ranging to be near and above Ichimoku cloud waiting for direction. Trading Summary : bullish
0 The MRNA doesn’t have other trading ideas at this time
Browse ready-made trading ideas or select a symbol and create your own
Go to Charts and Trading Ideas